Directory
>
Michael Kaufman
Michael Kaufman
VP of Chemistry and Preclinical Development | Deciphera Pharmaceuticals
United States
Michael Kaufman
Summary
Michael Kaufman is a seasoned professional in the pharmaceutical and medicine manufacturing industry, currently serving as the Vice President of Chemistry and Preclinical Development at Deciphera Pharmaceuticals. With expertise spanning drug design, development, and discovery, he is well-versed in the complexities of medicinal chemistry and organic synthesis. Michael's commitment to advancing pharmaceutical science is evident through his leadership in preclinical development and his knowledge of GMP and patents. His role at Deciphera highlights his ability to lead change and drive innovation in drug development processes. Despite a lack of detailed educational background, his extensive experience and seniority reflect a deep understanding of the industry. His passion for advancing healthcare solutions is complemented by his technical acumen in NMR and organic chemistry. Michael is a pivotal figure in his organization, contributing to the development of groundbreaking therapies.
Michael Kaufman
Work Experience
VP of Chemistry and Preclinical Development at
Deciphera Pharmaceuticals
Present
Frequently Asked Questions about Michael Kaufman
What is Michael Kaufman email address?
Michael Kaufman's primary email address is ********@advantech-ny.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Kaufman work for?
Michael Kaufman is a VP of Chemistry and Preclinical Development at Deciphera Pharmaceuticals, a company specializing in Pharmaceutical & Medicine Manufacturing.
How can I directly contact Michael Kaufman?
To contact Michael Kaufman directly, you can use the email address ********@advantech-ny.com. Complete contact information is available upon registration with Muraena.
Who is Michael Kaufman?
Michael Kaufman is a seasoned professional in the pharmaceutical and medicine manufacturing industry, currently serving as the Vice President of Chemistry and Preclinical Development at Deciphera Pharmaceuticals. With expertise spanning drug design, development, and discovery, he is well-versed in the complexities of medicinal chemistry and organic synthesis. Michael's commitment to advancing pharmaceutical science is evident through his leadership in preclinical development and his knowledge of GMP and patents. His role at Deciphera highlights his ability to lead change and drive innovation in drug development processes. Despite a lack of detailed educational background, his extensive experience and seniority reflect a deep understanding of the industry. His passion for advancing healthcare solutions is complemented by his technical acumen in NMR and organic chemistry. Michael is a pivotal figure in his organization, contributing to the development of groundbreaking therapies.
Michael`s contact details
********@advantech-ny.com
********@deciphera.com
Colleagues
VP, Head of Commercial International & Iberia GM
VP, Quality Assurance
Vice President
Vice President, Pharmaceutical Development & Manufacturing
Vice President, Head of Biometrics
Senior Vice President, US Commercial
Executive Director and Head of Global Medical Writing & Clinical Trial Disclosure
Executive Director, Clinical Operations
VP, Head of Pharmacovigilance
General Manager DACH